Jinwu Financial News | Path to Health (02587) starts offering shares today and plans to issue 25 million shares. Of these, 10% are for public sale in Hong Kong and the rest are international placements. The offering price per share ranges from HK$7.8-HK$8.8, 500 shares per lot, and an entry fee of HK$4,444.38. The shares are expected to be listed on December 30. CCB International is the sole sponsor.
Based on a median offering price of HK$8.3, it is anticipated that approximately 60.5% of the capital raised will be used for business development, including 33.5% and 27% for healthcare services and corporate services and digital marketing services respectively; about 21% is expected to be used for strategic investments or acquisitions; about 14.5% is expected to be used for R&D; and about 4% is expected to be used for working capital and general corporate purposes.
